Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Air France KLM SA
XBER:AFR0
|
FR |
|
Ather Energy Ltd
NSE:ATHERENERG
|
IN |
|
Taiyo Koki Co Ltd
TSE:6164
|
JP |
Tianjin Tianyao Pharmaceuticals Co Ltd
Research & Development
Tianjin Tianyao Pharmaceuticals Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488
|
Research & Development
-¥159m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Research & Development
-¥2.9B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Research & Development
-¥7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Research & Development
-¥356.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Research & Development
-¥1.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Research & Development
-¥1.4B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Tianjin Tianyao Pharmaceuticals Co Ltd
Glance View
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, development, production, and sales of corticosteroids and amino acid raw materials and preparations. The company is headquartered in Tianjin, Tianjin and currently employs 2,635 full-time employees. The company went IPO on 2001-06-18. The firm's primary products include corticosteroid bulk pharmaceutical chemicals (BPCs), amino acid BPCs and intermediate, such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinolone acetate, prednisone acetate, triamcinolone acetonide, propranolol propionate and betamethasone, among others. The firm mainly distributes its products in domestic and overseas markets.
See Also
What is Tianjin Tianyao Pharmaceuticals Co Ltd's Research & Development?
Research & Development
-159m
CNY
Based on the financial report for Sep 30, 2025, Tianjin Tianyao Pharmaceuticals Co Ltd's Research & Development amounts to -159m CNY.
What is Tianjin Tianyao Pharmaceuticals Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-1%
Over the last year, the Research & Development growth was 8%. The average annual Research & Development growth rates for Tianjin Tianyao Pharmaceuticals Co Ltd have been -9% over the past three years , -1% over the past five years .
